Withaphysalin A
Based on 1 Customer Validation
Withaphysalin A is a withanolide compound with anti-inflammatory and antioxidant activities. Withaphysalin A inhibits LPS (HY-D1056)-induced nuclear translocation of NF-κB p65, as well as phosphorylation of STAT3, ERK, JNK and p38 MAPK. Withaphysalin A upregulates the expression of HO-1. Withaphysalin A inhibits LPS-induced production of NO, PGE2, IL-1β, IL-6 and TNF-α. Withaphysalin A downregulates LPS-induced expression of iNOS and COX-2. Withaphysalin A interacts with B-cell activating factor protein (BAFF) to exert inhibitory effects. Withaphysalin A exhibits ELOVL6 inhibitory activity. Withaphysalin A can be used in the research of inflammatory diseases, nephrotic syndrome and chronic myeloid leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 57423-72-0
- Formule: C28H34O6
- Masse moléculaire:466.57
-
Stockage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Voir tous les produits spécifiques à Isoform TNF Receptor
More
Activité biologique
Description
In Vitro
Withaphysalin A (0-50 μM; 1 h) potently inhibits LPS-induced NO production in RAW264.7 cells, with an IC50 of 20.12 μM, and suppresses LPS-induced PGE2 production[1].
Withaphysalin A (0-50 μM; 1 h) dose-dependently inhibits LPS-induced production of IL-6, TNF-α, and IL-1β in RAW264.7 cells, with both protein and mRNA levels suppressed[1].
Withaphysalin A (0-50 μM; 1) dose-dependently inhibits LPS-induced expression of iNOS and COX-2 (at both protein and mRNA levels) in RAW264.7 cells[1].
Withaphysalin A (0-50 μM; 1 h) inhibits LPS-induced phosphorylation of ERK, JNK, p38 MAPK, and STAT3, and induces HO-1 protein expression in LPS-stimulated RAW264.7 cells[1].
Withaphysalin A (50 μM; 1 h) inhibits LPS-induced nuclear translocation of NF-κB p65 in RAW264.7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LPS-stimulated mouse macrophage RAW264.7 cells
-
Concentration:0, 12.5, 25, 50 μM
-
Incubation Time:1 h
-
Result:Significantly reduced LPS-induced PGE2 release at all tested concentrations compared to the LPS-only group.
Dose-dependently suppressed LPS-induced release of IL-6, TNF-α, and IL-1β protein levels.
-
Cell Line:LPS-stimulated mouse macrophage RAW264.7 cells
-
Concentration:0, 12.5, 25, 50 μM
-
Incubation Time:1 h
-
Result:Dose-dependently reduced LPS-induced mRNA expression of IL-6, TNF-α, and IL-1β.
-
Cell Line:LPS-stimulated mouse macrophage RAW264.7 cells
-
Concentration:0, 12.5, 25, 50 μM
-
Incubation Time:1 h
-
Result:Dose-dependently reduced LPS-induced iNOS and COX-2 protein expression, with significant suppression.
Significantly inhibited p-JNK、p-p38、p-ERK、MAPK、STAT3 phosphorylation.
Dose-dependently increased LPS-induced HO-1 protein expression.
-
Cell Line:LPS-stimulated mouse macrophage RAW264.7 cells
-
Concentration:50 μM
-
Incubation Time:1 h
-
Result:Significantly reduced LPS-induced nuclear translocation of NF-κB p65 at 50 μM.
Chemical Information
-
CAS No. 57423-72-0
-
Appearance Solid
-
Masse moléculaire 466.57
-
Formule C28H34O6
-
Color White to off-white
-
SMILES
CC(CC([C@@]1(OC([C@]23CCC4C([C@@]2(CCC31)O)CC=C5CC=CC([C@]45C)=O)=O)C)O6)=C(C)C6=O
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Protocole
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Pureté et documentation
-
Fiche technique (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Li RJ, et al. The Anti-inflammatory Activities of Two Major Withanolides from Physalis minima Via Acting on NF-κB, STAT3, and HO-1 in LPS-Stimulated RAW264.7 Cells. Inflammation. 2017;40(2):401-413. [Content Brief]
[2]. Kardani AK, et al. Inhibition of B-cell activating factor activity using active compounds from Physalis angulata in the mechanism of nephrotic syndrome improvement: A computational approach. Narra J. 2024 Dec;4(3):e859. [Content Brief]
[3]. Tasneem A, et al. Exploring phytochemical inhibitors of fatty acid elongase ELOVL6 for targeted treatment of chronic myeloid leukemia: A comprehensive network-based drug discovery approach. Comput Biol Med. 2026;201:111342. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)